Add BrightSurf on Google Email

Most stroke patients don't get clot-busting treatment in timely manner, study finds

Researchers found that less than one-third of acute stroke patients treated with clot-busting drug tPA receive it within 60 minutes of hospital arrival. Timely tPA administration is linked to lower in-hospital mortality and fewer complications, with every 15-minute reduction associated with a 5% lower risk of death.

Scientists climb Mt. Everest to explain how hearts adapt and recover from low oxygen

Researchers studied physicians and scientists trekking to Mt. Everest Base Camp, finding extensive but reversible changes in heart function after exposure to low oxygen levels. The findings suggest that heart problems experienced by seriously ill patients may be reversible once oxygen levels are returned to normal.

JCI table of contents: Jan. 25, 2011

Researchers found that N-acetylcysteine can decrease the size of von Willebrand factor multimers in mice, potentially treating life-threatening blood disorder thrombotic thrombocytopenic purpura (TTP). However, chronic use of drugs targeting Notch1 raises concerns due to its link to vascular tumors and lethal hemorrhage in mice.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJan 25, 2011

Activation of PPAR α/γ mediates remote IPC against myocardial infarction

Researchers have identified PPAR alpha and gamma as key signaling elements in remote ischemic preconditioning (IPC), a powerful form of cardioprotection that can reduce myocardial infarct size by up to 50%. The activation of these nuclear receptors is linked to the production of nitric oxide, a well-established preconditioning-mimetic.

SourceSociety for Experimental Biology and Medicine·JournalExperimental Biology and Medicine·DateJan 17, 2011

Patients may not have to stop taking anti-platelets for some surgeries

A recent study found that patients undergoing carotid endarterectomy (CEA) can safely continue taking clopidogrel, but bleeding complications are associated with using a Dacron patch. The study analyzed 260 consecutive patients and found no significant difference in operative blood loss between those on clopidogrel and aspirin alone.

SourceMinneapolis Heart Institute Foundation·JournalAnnals of Vascular Surgery·DateDec 9, 2010

Clinical science: Special reports I

Researchers identified irregular heartbeat in pacemaker recipients as a potential stroke risk factor. Meanwhile, disparities in cardiovascular care persist despite healthcare reform, with African-Americans and those with lower socioeconomic status receiving fewer invasive procedures. Stress tests using exercise electrocardiography and ...

Synchronizing a failing heart

A new therapeutic implant has been proven to synchronize and strengthen a fading heart beat, reducing the risk of death by 24% compared to current treatment. The device therapy, called cardiac resynchronization therapy (CRT), also improves quality of life and reduces hospital admissions for worsening heart failure.

SourceUniversity of Ottawa Heart Institute·JournalNew England Journal of Medicine·DateNov 14, 2010

DNA sequence variations linked to electrical signal conduction in the heart

A study of nearly 50,000 people has identified DNA sequence variations associated with cardiac electrical activity, which may lead to novel approaches to prevent or treat serious rhythm disorders. The findings provide new clues about the biologic pathways that influence cardiac conduction and identify genes and genetic pathways involve...

Additional cardiac testing vital for patients with anxiety and depression

A new study published in the Journal of Cardiopulmonary Rehabilitation and Prevention found that patients with anxiety disorders are more likely to have undetected heart problems during electrocardiogram tests. The study suggests that administering a brief questionnaire before conducting ECGs can help identify patients at risk.

SourceConcordia University·JournalJournal of Cardiopulmonary Rehabilitation and Prevention·DateNov 11, 2010

New heart pump to provide temporary assist for infants, adults

Researchers have developed a new type of heart pump to improve the survival rate for infants undergoing surgeries to correct univentricular circulation. The innovative 'viscous impeller pump' can be inserted through a catheter and expands to form two cones, spinning at 10,000 rpm to efficiently pump blood.

SourcePurdue University·JournalJournal of Thoracic and Cardiovascular Surgery·DateNov 9, 2010

Scorpion has welcome sting for heart bypass patients

Researchers have discovered a potent toxin in scorpion venom that can prevent neointimal hyperplasia, a leading cause of heart bypass graft failure. The compound, margatoxin, is up to 100 times more effective than other known inhibitors, offering new hope for patients undergoing bypass surgery.

SourceUniversity of Leeds·JournalCardiovascular Research·DateOct 22, 2010

Doctors evaluating heart problems should consider checking fat deposits around the heart

Recent research suggests that measuring fatty tissue around the heart is an even better predictor of major heart problems. Noninvasive CT scanning can provide this important information. The researchers conclude that assessment could add meaningfully to clinical risk assessment and generate CT information regarding plaque buildup.

SourceCedars-Sinai Medical Center·JournalJournal of the American College of Cardiology·DateOct 6, 2010

IT can help CVD management

A recent study published in PLOS Medicine suggests that IT-based programs can support clinicians to close gaps in CVD care delivery, including risk assessment and patient self-management. The authors emphasize the need for a supportive social and political environment to fully realize the potential of these programs.

SourcePLOS·JournalPLOS Medicine·DateAug 24, 2010

Mayo's 'smart' adult stem cells repair hearts

Researchers demonstrate that rationally guided human adult stem cells can effectively heal, repair, and regenerate damaged heart tissue. The study shows improved heart function recovery, reduced scars, and increased survival rate in mouse models with heart failure.

SourceMayo Clinic·JournalJournal of the American College of Cardiology·DateAug 16, 2010